BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 205442)

  • 1. Immune response of the Syrian golden hamster to SV40 induced and transplantable tumors.
    Goldrosen MH; Dent PB
    Fed Proc; 1978 May; 37(7):2092-5. PubMed ID: 205442
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum factors modulating host immunity to SV40 tumor cells.
    Lausch RN; Prather SO
    Fed Proc; 1978 May; 37(7):2095-6. PubMed ID: 205443
    [No Abstract]   [Full Text] [Related]  

  • 3. [SV 40 transformed cells obtained from a synergeic hamster line (author's transl)].
    Zuinghedau J; Duthu A; de Vaux Saint Cyr C
    Bull Cancer; 1979; 66(4):383-5. PubMed ID: 230874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Syrian hamster sensitivity to tumor cell inoculation in the period of pregnancy and nursing the cubs].
    Vendrov EL
    Biull Eksp Biol Med; 1980 Aug; 90(8):201-3. PubMed ID: 6250661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunization of hamsters against tumors induced by the SV40 virus].
    Ciobanu Z; Fenyves A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):109-16. PubMed ID: 4328000
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related and thymus-dependent rejection of adenovirus 2-transformed cell tumors in the Syrian hamster.
    Cook JL; Lewis AM; Kirkpatrick CH
    Cancer Res; 1979 Sep; 39(9):3335-40. PubMed ID: 314331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of sera from SV40-immunized and tumor-bearing hosts for blocking activity and antibody-dependent cellular cytotoxicity.
    Lausch RN; Sofranko J; Prather SO
    J Immunol; 1975 Sep; 115(3):682-7. PubMed ID: 168264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge.
    Prather SO; Geller RW; Lausch RN
    J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of BCG vaccination on the primary and transplantable hamster tumors induced by SV40 and on the specific SV40 virus-induced antitumor immunity.
    Zhalgasbayeva GT
    Neoplasma; 1976; 23(2):129-36. PubMed ID: 180441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symposium report. Hamster immune responsiveness and experimental models of infectious and oncologic diseases.
    Streilein JW
    Fed Proc; 1981 Jul; 40(9):2343-52. PubMed ID: 7250380
    [No Abstract]   [Full Text] [Related]  

  • 12. Spectrum of tumorigenic phenotypes among adenovirus 2-, adenovirus 12-, and simian virus 40-transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions.
    Lewis AM; Cook JL
    Cancer Res; 1982 Mar; 42(3):939-44. PubMed ID: 6277479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of allograft-rejection resistance in simian virus 40-transformed hamster cells and its possible role in tumor development.
    Lewis AM; Cook JL
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2886-9. PubMed ID: 6248874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic and antimitogenic transforming growth factors secreted by adenovirus 2- and simian virus 40-transformed hamster cells: possible roles in promoting tumorigenesis.
    Akagi K; Murai K; Haddada H; Levine AS; Patch CT
    Cancer Res; 1987 Aug; 47(15):4086-92. PubMed ID: 3038307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV40 transplantation antigen: relationship to SV40-specific proteins.
    Tevethia SS; Greenfield RS; Flyer DC; Tevethia MJ
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 1,():235-42. PubMed ID: 6253137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantitative analysis of the immunogenic activity of SV40 virus and the cells of tumors induced by this virus].
    Kliuchareva TE
    Biull Eksp Biol Med; 1978 Aug; 86(8):223-5. PubMed ID: 210866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo blocking of SV40 virus-induced antitumor resistance by Syrian hamster sera from early stages of primary SV40 carcinogenesis.
    Volpe EA
    Neoplasma; 1976; 23(4):345-53. PubMed ID: 187966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in immunosensitivity of SV40-transformed hamster cells.
    Tevethia SS; McMillan VL; Kaplan PM; Bushong SC
    J Immunol; 1971 May; 106(5):1295-300. PubMed ID: 4326127
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-induced cellular immunity to simian virus 40 tumor-specific surface antigen(s) in adult LVG:LAK hamsters.
    Weppner WA; Coggin JH
    J Natl Cancer Inst; 1980 Apr; 64(4):757-63. PubMed ID: 6245298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.